alzheimers disease
FDA approves a second Alzheimer's drug that can modestly slow disease
The Food and Drug Administration approved Eli Lilly's Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer's
More Stories
More Stories
WATCH LIVE